BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25535009)

  • 1. The role of the potassium channel gene KCNK2 in major depressive disorder.
    Congiu C; Minelli A; Bonvicini C; Bortolomasi M; Sartori R; Maj C; Scassellati C; Maina G; Trabucchi L; Segala M; Gennarelli M
    Psychiatry Res; 2015 Feb; 225(3):489-92. PubMed ID: 25535009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
    Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
    Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of GRIK4 gene in treatment-resistant depression.
    Milanesi E; Bonvicini C; Congiu C; Bortolomasi M; Gainelli G; Gennarelli M; Minelli A
    Genet Res (Camb); 2015 Jul; 97():e14. PubMed ID: 26139080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome.
    Zhang C; Wu Z; Hong W; Wang Z; Peng D; Chen J; Yuan C; Yu S; Xu L; Fang Y
    J Affect Disord; 2014 Feb; 155():288-94. PubMed ID: 24321200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study.
    Perlis RH; Moorjani P; Fagerness J; Purcell S; Trivedi MH; Fava M; Rush AJ; Smoller JW
    Neuropsychopharmacology; 2008 Nov; 33(12):2810-9. PubMed ID: 18288090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the TLR4 gene with depressive symptoms and antidepressant efficacy in major depressive disorder.
    Wang J; Yang C; Liu Z; Li X; Liu M; Wang Y; Zhang K; Sun N
    Neurosci Lett; 2020 Sep; 736():135292. PubMed ID: 32763359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The associations of CNR1 SNPs and haplotypes with vulnerability and treatment response phenotypes in Han Chinese with major depressive disorder: A case-control association study.
    Yang C; Nolte IM; Ma Y; An X; Bosker FJ; Li J
    Mol Genet Genomic Med; 2021 Sep; 9(9):e1752. PubMed ID: 34355541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of monoamine-related gene polymorphisms on hippocampal volume in treatment-resistant depression.
    Phillips JL; Batten LA; Tremblay P; Aldosary F; Du L; Blier P
    Acta Neuropsychiatr; 2015 Dec; 27(6):353-61. PubMed ID: 25990886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response.
    Yu YW; Chen TJ; Hong CJ; Chen HM; Tsai SJ
    Neuropsychopharmacology; 2003 Jun; 28(6):1182-5. PubMed ID: 12700687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder.
    Crisafulli C; Shim DS; Andrisano C; Pae CU; Chiesa A; Han C; Patkar AA; Lee SJ; Serretti A; De Ronchi D
    Psychiatry Res; 2012 Jun; 198(1):39-46. PubMed ID: 22386572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAS -670A>G genetic polymorphism Is associated with Treatment Resistant Depression.
    Santos M; Carvalho S; Lima L; Mota-Pereira J; Pimentel P; Maia D; Correia D; Gomes S; Cruz A; Medeiros R
    J Affect Disord; 2015 Oct; 185():164-9. PubMed ID: 26186532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance.
    Fabbri C; Corponi F; Albani D; Raimondi I; Forloni G; Schruers K; Kasper S; Kautzky A; Zohar J; Souery D; Montgomery S; Cristalli CP; Mantovani V; Mendlewicz J; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():203-210. PubMed ID: 28989100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of a Single Nucleotide Polymorphism in SIGMAR1 on Depressive Symptoms in Major Depressive Disorder and Bipolar Disorder.
    Mandelli L; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS; Pae CU; Serretti A
    Adv Ther; 2017 Mar; 34(3):713-724. PubMed ID: 28144920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.
    Calati R; Crisafulli C; Balestri M; Serretti A; Spina E; Calabrò M; Sidoti A; Albani D; Massat I; Höfer P; Amital D; Juven-Wetzler A; Kasper S; Zohar J; Souery D; Montgomery S; Mendlewicz J
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():271-8. PubMed ID: 23537502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A major single nucleotide polymorphism of the PDLIM5 gene associated with recurrent major depressive disorder.
    Liu Z; Liu W; Xiao Z; Wang G; Yin S; Zhu F; Wang H; Cheng J; Wang X; He X; Li W
    J Psychiatry Neurosci; 2008 Jan; 33(1):43-6. PubMed ID: 18197271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study.
    Schosser A; Carlberg L; Calati R; Serretti A; Massat I; Spindelegger C; Linotte S; Mendlewicz J; Souery D; Zohar J; Montgomery S; Kasper S
    Int J Neuropsychopharmacol; 2017 Oct; 20(10):782-787. PubMed ID: 28977521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
    Chang HS; Won E; Lee HY; Ham BJ; Lee MS
    Behav Brain Res; 2015 Oct; 292():116-24. PubMed ID: 26055202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain Volume-Related Polymorphisms of the Glycogen Synthase Kinase-3β Gene and Their Effect on Antidepressant Treatment in Major Depressive Disorder.
    Sunada N; Takekita Y; Nonen S; Wakeno M; Koshikawa Y; Ogata H; Kinoshita T; Kato M
    Neuropsychobiology; 2019; 78(3):136-144. PubMed ID: 31189175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder--a European multicenter study.
    Schosser A; Calati R; Serretti A; Massat I; Kocabas NA; Papageorgiou K; Linotte S; Mendlewicz J; Souery D; Zohar J; Juven-Wetzler A; Montgomery S; Kasper S
    Eur Neuropsychopharmacol; 2012 Apr; 22(4):259-66. PubMed ID: 21940152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.